CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE

Generic: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE

Solco Healthcare LLCManufacturer
ORALRoute
CANDESARTAN CILEXETILActive Substance
2018-04-11Original Approval

CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE is FDA application ANDA207455, sponsored by PRINSTON. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DYSPNOEA
1,024 reports
2
FATIGUE
942 reports
3
HEADACHE
897 reports
4
OFF LABEL USE
889 reports
5
NAUSEA
864 reports
6
DIZZINESS
812 reports
7
DIARRHOEA
783 reports
8
DRUG INEFFECTIVE
777 reports
9
VOMITING
734 reports
10
PAIN
733 reports